Increased plasma markers of inflammation and endothelial dysfunction in patients with different degree of chronic heart failure (CHF)

被引：0
|
作者：
Radovanovic, Slavica [1 ]
Savic-Radojevic, Ana [2 ]
Simic, Dragan [3 ]
Krotin, Mirjana [1 ]
Djokovic, Aleksandra [1 ]
Ninkovic, Nebojsa [1 ]
Zdravkovic, Marija [1 ]
Saric, Jelena [1 ]
Zivanovic, Irena [1 ]
Simic, Tatjana [2 ]
机构：
[1] Univ Hosp Bezanijska Kosa, Belgrade, Serbia
[2] Univ Sch Med, Inst Biochem, Belgrade, Serbia
[3] Belgrade Med Sch, Clin Cardiol, Belgrade, Serbia
来源：
CIRCULATION | 2012年 / 125卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AP039
引用
收藏
页码：E750 / E750
页数：1
相关论文
共 50 条
  • [21] Dynamics of laboratory endothelial dysfunction markers in patients with acute decompensated chronic heart failure, treated with anticoagulants
    Shevchenko, I. Irina
    Shavarov, A. A.
    Kiyakbayev, G. K.
    Moiseev, V. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 125 - 125
  • [22] Physical training reduces peripheral inflammatory markers associated with endothelial dysfunction in patients with chronic heart failure
    Adamopoulos, S
    Parissis, J
    Kroupis, C
    Georgiadis, M
    Karatzas, D
    Karavolias, GK
    Koniavitou, K
    Coats, AJS
    Kremastinos, DTH
    EUROPEAN HEART JOURNAL, 2000, 21 : 259 - 259
  • [23] The features of cardiohemodynamic parameters, markers of kidney dysfunction and immune inflammation in patients with chronic heart failure and chronic kidney disease
    Mykhailova, I.
    Lapshina, L.
    Tytova, G.
    Kravchyn, P.
    Zolotaikina, V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S302 - S303
  • [24] EFFECTS OF SIMVASTATIN ON MARKERS OF INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND APOPTOSIS IN CHRONIC HEMODIALYSIS PATIENTS
    Kirmizis, D.
    Papagianni, A.
    Belechri, A-M
    Efstratiadis, G.
    Alexopoulos, E.
    Memmos, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [25] Markers of renal dysfunction in chronic heart failure
    Matskevich, S. A.
    Atroschenko, E. S.
    Barbuk, O. A.
    Belskaya, M. I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 367 - 368
  • [26] Growth hormone corrects endothelial dysfunction in patients with chronic heart failure
    Napoli, R
    Guardasole, V
    Matarazzo, M
    Palmieri, EA
    Oliviero, U
    Fazio, S
    Sacca, L
    CIRCULATION, 2001, 104 (17) : 366 - 367
  • [27] Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure
    Hornig, B
    Arakawa, N
    Drexler, H
    EUROPEAN HEART JOURNAL, 1998, 19 : G48 - G53
  • [28] Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure
    Katz, SD
    Hryniewicz, K
    Hriljac, I
    Balidemaj, K
    Dimayuga, C
    Hudaihed, A
    Yasskiy, A
    CIRCULATION, 2005, 111 (03) : 310 - 314
  • [29] Evaluation of endothelial dysfunction in patients with arterial hypertension and chronic heart failure
    Sapatyi, AAndriy
    Kupnovytska, I. G.
    Belegai, R. I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 173 - 173
  • [30] Correlation of selected chronic inflammation and endothelial dysfunction markers with different stages of chronic kidney disease (CKD)
    Pawlaczyk, Krzysztof
    Krupa, Dariusz
    Simachowicz, Agnieszka
    Oko, Andrzej
    Lindholm, Bengt
    Czekalski, Stanislaw
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 389 - 389
12345